Annual ROA
-355.16%
-195.11%-121.91%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual return on assets is -355.16%, with the most recent change of -195.11% (-121.91%) on December 1, 2023.
- During the last 3 years, NRSN annual ROA has risen by +7.87% (+2.17%).
- NRSN annual ROA is now -904.70% below its all-time high of -35.35%, reached on December 31, 2021.
Performance
NRSN ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-685.86%
-315.50%-85.19%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly return on assets is -685.86%, with the most recent change of -315.50% (-85.19%) on September 1, 2024.
- Over the past year, NRSN quarterly ROA has dropped by -377.96% (-122.75%).
- NRSN quarterly ROA is now -1225.33% below its all-time high of -51.75%, reached on March 31, 2022.
Performance
NRSN Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
NRSN ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -121.9% | -122.8% |
| 3 y3 years | +2.2% | -1085.0% |
| 5 y5 years | -177.6% | -151.5% |
NRSN ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -904.7% | at low | -1225.3% | at low |
| 5 y | 5-year | -904.7% | +2.2% | -1225.3% | at low |
| alltime | all time | -904.7% | +2.2% | -1225.3% | at low |
NeuroSense Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -685.86%(+85.2%) |
| Jun 2024 | - | -370.36%(+20.3%) |
| Mar 2024 | - | -307.90%(+48.5%) |
| Dec 2023 | -355.16%(+121.9%) | -207.31%(+35.4%) |
| Sep 2023 | - | -153.16%(-9.2%) |
| Jun 2023 | - | -168.72%(+13.4%) |
| Mar 2023 | - | -148.83%(+28.9%) |
| Dec 2022 | -160.05% | -115.46%(+44.4%) |
| Sep 2022 | - | -79.97%(+38.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -57.88%(+11.8%) |
| Mar 2022 | - | -51.75%(-20.0%) |
| Dec 2021 | -35.35%(-90.3%) | - |
| Dec 2021 | - | -64.69%(-84.9%) |
| Sep 2021 | - | -428.03%(+29.1%) |
| Jun 2021 | - | -331.56%(+21.6%) |
| Mar 2021 | - | -272.66% |
| Dec 2020 | -363.03%(+183.7%) | - |
| Dec 2019 | -127.96% | - |
FAQ
- What is NeuroSense Therapeutics annual return on assets?
- What is the all time high annual ROA for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual ROA year-on-year change?
- What is NeuroSense Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly ROA year-on-year change?
What is NeuroSense Therapeutics annual return on assets?
The current annual ROA of NRSN is -355.16%
What is the all time high annual ROA for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual return on assets is -35.35%
What is NeuroSense Therapeutics annual ROA year-on-year change?
Over the past year, NRSN annual return on assets has changed by -195.11% (-121.91%)
What is NeuroSense Therapeutics quarterly return on assets?
The current quarterly ROA of NRSN is -685.86%
What is the all time high quarterly ROA for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly return on assets is -51.75%
What is NeuroSense Therapeutics quarterly ROA year-on-year change?
Over the past year, NRSN quarterly return on assets has changed by -377.96% (-122.75%)